Redesigning the Pharma Commercial Operating Model for the AI Era
Explore how AI is moving beyond isolated tools and becoming part of a governed commercial operating model for life sciences.
For years, AI in pharma commercial has lived at the edges of the operating model — a chatbot here, a recommendation engine there, a pilot that never quite scaled. That era is ending. The organizations pulling ahead are not the ones with the most AI tools; they are the ones that have redesigned the operating model itself so AI has somewhere governed, permissioned, and durable to live.
A governed operating model means data, content, channels, and field insight are connected through a common layer of context — not stitched together after the fact. It means every recommendation an agent makes can be traced back to a source, a policy, and a person accountable for it. And it means the organization is investing in reusable capability, not one-off integrations that have to be rebuilt for every new use case.
This is the shift from AI as a feature to AI as infrastructure: commercial intelligence that is always on, always governed, and always improving the next engagement because of what it learned from the last one.
